Webinar

Transformative Evidence Generation Solutions Leveraging Federated AI

Available on-demand

60 Minutes

Join us for this one-hour, comprehensive discussion about the importance of an innovative approach to data collection to inform real-world research. Leveraging privacy-preserving data collaboration and advance analytics, UBC and SymetryML has integrated and built a next-gen, globally connected observational research model. Discover how this transformative evidence generation solution, combining decades of scientific real-world expertise with breakthrough Federated AI, can help you overcome common challenges and inform your clinical and commercial data acquisition goals.

In this webinar we will explore:

The value of an AI-Driven Virtual Evidence Platform
Understanding the Data Elements Matrix (DEM) and the opportunity it allows the market
Elements that support AI-driven virtualized program designs
And more

Speakers

Aaron Berger

SVP, Head of Evidence Development

UBC

Aaron leads a multi-disciplinary team that designs and executes modernized solutions leveraging forward-leaning technology and research designs that deliver fit-for-purpose evidence on the safety and effectiveness of treatments for patients. He is responsible for the development of real-world data and real-world evidence technology architectures and decentralized research solutions to drive greater insight into the safety profile and value proposition of medicines.

Dustin O’Dell

Co-Founder & CEO

SymetryML

Repeat entrepreneur & founder with successful exits. Over 12 years of experience in commercializing Data, AI, and ML technologies. As 6th employee and BD executive, led go-to-market strategies and drove $20M in revenue for early-stage startup AdTheorent. Co-founded Barometric which was acquired in 2 years by Claritas.

Eric Faulkner

Chief Scientific Officer

SymetryML

A globally recognized industry expert and senior executive spanning evidence development, HEOR, RWD/RWE, Market Access, and Commercial. Prior Eric was Global VP of RWE at Novartis and VP member RWE and Market Access executive teams at PPD/Evidera.

Register here to watch on-demand!

Already registered? Click here to login.

Duration:

60 Minutes